Jubilant inks pact with Orion Corporation
The drug discovery pact is to develop medicines in the neuroscience therapeutic area.
New Delhi, May 13, 2014: Jubilant Life Sciences has signed a drug discovery pact with Finland based Orion Corporation to develop medicines in the neuroscience therapeutic area.
The company said in a statement today that Jubilant Biosys, a Bengaluru based subsidiary of Jubilant Life Sciences has signed a drug collaboration agreement with Orion Corporation.
The company also said that the deal is aimed at developing drug that can benefit large population with unmet needs in the pain management area.
It may be noted here that Orion will provide royalty to Jubilant and will retain ownership of the compounds developed under the collaboration with exclusive worldwide rights, as per the terms of the royalty based alliance.
Jubilant will offer integrated drug discovery services across synthetic and medicinal chemistry including scale up and pre-clinical facilities, it added.